Mark Alan Goldberg

Insider Reports History

Location
128 Spring Street, Suite 520, Lexington, MA
Signature
/s/ Melissa Masse, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Alan Goldberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GLYCOMIMETICS INC Director Common Stock 24.8K $74.5K $3.00 Mar 29, 2024 Direct
GLYCOMIMETICS INC Director Common Stock 11.5K $34.5K $3.00 Mar 29, 2024 By family trusts
Blueprint Medicines Corp Director Common Stock 0 $0 $101.84 Jul 17, 2025 Direct
ImmunoGen, Inc. Director Common Stock 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. Director Deferred Share Unit 0 $0 $29.30 Feb 12, 2024 Direct
ImmunoGen, Inc. Director Restricted Stock Unit 0 $0 $29.30 Feb 12, 2024 Direct
GLYCOMIMETICS INC Director Stock Option (right to buy) 40K May 1, 2024 Direct
IDERA PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 26K Jun 23, 2022 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 0 Jul 17, 2025 Direct
ImmunoGen, Inc. Director Stock Option (Right to Buy) 0 $5.19 Feb 12, 2024 Direct

Insider Reports Filed by Mark Alan Goldberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Jul 17, 2025 10 $0 4 Jul 21, 2025 Director
BPMC Blueprint Medicines Corp Jun 18, 2025 1 $500K 4 Jun 24, 2025 Director
BPMC Blueprint Medicines Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
GLYC GLYCOMIMETICS INC May 1, 2024 1 $0 4 May 1, 2024 Director
GLYC GLYCOMIMETICS INC Mar 29, 2024 1 $13.8K 4 Apr 2, 2024 Director
IMGN ImmunoGen, Inc. Feb 12, 2024 13 $0 4 Feb 12, 2024 Director
IMGN ImmunoGen, Inc. Dec 29, 2023 1 $16.9K 4 Jan 3, 2024 Director
GLYC GLYCOMIMETICS INC Dec 29, 2023 1 $13.8K 4 Jan 2, 2024 Director
IMGN ImmunoGen, Inc. Oct 30, 2023 3 -$3.8K 4 Nov 1, 2023 Director
GLYC GLYCOMIMETICS INC Sep 30, 2023 1 $13.8K 4 Oct 3, 2023 Director
IMGN ImmunoGen, Inc. Sep 29, 2023 1 $16.9K 4 Oct 2, 2023 Director
IMGN ImmunoGen, Inc. Jun 30, 2023 1 $16.9K 4 Jul 5, 2023 Director
BPMC Blueprint Medicines Corp Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
IMGN ImmunoGen, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
GLYC GLYCOMIMETICS INC May 19, 2023 1 $0 4 May 22, 2023 Director
IMGN ImmunoGen, Inc. Mar 31, 2023 1 $16.9K 4 Apr 4, 2023 Director
IMGN ImmunoGen, Inc. Dec 30, 2022 1 $0 4 Jan 4, 2023 Director
IMGN ImmunoGen, Inc. Sep 30, 2022 1 $0 4 Oct 4, 2022 Director
IMGN ImmunoGen, Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Director
IDRA IDERA PHARMACEUTICALS, INC. Jun 23, 2022 1 $0 4 Jun 27, 2022 Director
BPMC Blueprint Medicines Corp Jun 21, 2022 2 $0 4 Jun 30, 2022 Director
IMGN ImmunoGen, Inc. Jun 15, 2022 2 $148K 4 Jun 17, 2022 Director
GLYC GLYCOMIMETICS INC May 18, 2022 1 $0 4 May 20, 2022 Director
IMGN ImmunoGen, Inc. Mar 31, 2022 1 $0 4/A Apr 20, 2022 Director
BPMC Blueprint Medicines Corp Mar 3, 2022 1 $300K 4 Mar 7, 2022 Director
IMGN ImmunoGen, Inc. Dec 31, 2021 1 $0 4 Jan 4, 2022 Director
IMGN ImmunoGen, Inc. Sep 30, 2021 1 $0 4 Oct 1, 2021 Director
IMGN ImmunoGen, Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
IMGN ImmunoGen, Inc. Jun 16, 2021 2 $298K 4 Jun 17, 2021 Director
IDRA IDERA PHARMACEUTICALS, INC. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
BPMC Blueprint Medicines Corp Jun 2, 2021 2 $0 4 Jun 4, 2021 Director
GLYC GLYCOMIMETICS INC May 18, 2021 2 $0 4 May 27, 2021 Director